Free Trial

Medifast Q2 2024 Earnings Report

Medifast logo
$18.47 -0.12 (-0.65%)
(As of 12:29 PM ET)

Medifast EPS Results

Actual EPS
$0.92
Consensus EPS
$0.36
Beat/Miss
Beat by +$0.56
One Year Ago EPS
$2.77

Medifast Revenue Results

Actual Revenue
$168.56 million
Expected Revenue
$160.44 million
Beat/Miss
Beat by +$8.12 million
YoY Revenue Growth
N/A

Medifast Announcement Details

Quarter
Q2 2024
Time
After Market Closes

Conference Call Resources

Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong (Ad)

Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.

Click here to watch this demo and decide for yourself.
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Medifast? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Medifast and other key companies, straight to your email.

About Medifast

Medifast (NYSE:MED), through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names. The company markets its products through point-of-sale transactions, as well as through ecommerce platform. Medifast, Inc. was founded in 1980 and is headquartered in Baltimore, Maryland.

View Medifast Profile

More Earnings Resources from MarketBeat

Upcoming Earnings